BAAM
TNDM icon

Baker Avenue Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Baker Avenue Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-26
Closed -$638 – 1734
2023
Q2 		$638 Buy
26
+10
+63% +$322 ﹤0.01% 1325
2023
Q1 		$650 Buy
16
+1
+7% +$41 ﹤0.01% 1328
2022
Q4 		$674 Buy
+15
New +$679 ﹤0.01% 1221

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Baker Avenue Asset Management's TNDM Position: Q3 2023 in Review

Baker Avenue Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 26 shares — an estimated $638 sold.

Baker Avenue Asset Management first reported a position in TNDM in Q4 2022 and held it in 3 quarters. The position peaked at $674 in Q4 2022. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • Baker Avenue Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 26 Tandem Diabetes Care shares in Q3 2023, an estimated $638.
  • Baker Avenue Asset Management first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 3 quarters.
  • Baker Avenue Asset Management's Tandem Diabetes Care position peaked at $674 in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Baker Avenue Asset Management's 13F filing for Q3 2023, filed 15 Nov 2023.